Skip to content

Sound Bioventures

Venture Capital Fund

  • CEO-Portal
  • Investor Portal
  • About
  • Team
  • Portfolio
  • Pipeline
  • Proposals
  • News
  • ESG
  • About
    • Team
    • Team Openings
    • Contact
    +
  • Portfolio
    • Aboleris
    • Artax Biopharma
    • Arthex
    • Breye Therapeutics
    • NephroDI
    • Teitur
    • Theolytics
    • VarmX
    +
  • Pipeline
  • Proposals
  • News
  • ESG
  • Press
  • Contact

Aboleris

Aboleris Pharma is a preclinical stage company, developing novel and unique therapeutic approaches to induce immune tolerance while preserving useful immune responses; with the aim to address signifi ...

AnaCardio

AnaCardio is a clinical stage company developing novel drugs to treat heart failure. The company was founded based on ground-breaking research from Karolinska Institute (Sweden) showing improved cont ...
Read about Artax Biopharma and their journey developing a revolutionary therapy for autoimmune diseases that makes a meaningful difference in patients lives.

Artax Biopharma

Artax Biopharma is a clinical stage biotechnology company that develops novel treatments for autoimmune diseases. The lead product, AX-158, is a first-in-class, oral small molecule that inhibits N ...
ARTHEx biotech

Arthex

ARTHEx Biotech is a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs. The Company’s lead investigational compound, ATX-01, is advanc ...

Breye Therapeutics

Breye Therapeutics is a clinical development stage company that developing new therapies within Opthalmology The lead program is Danegaptide – an oral drug that can both treat Diabetic Retinopathy ...

NephroDI

NephroDI is a pre-clinical stage company developing an oral small molecule drug for genetic (X-Linked) and drug induced (Tolvaptan and Lithium induced) Nephrogenic Diabetes Insipidus (NDI). The compo ...
Teitur Trophics

Teitur

Teitur is a preclinical stage company, developing novel therapeutics for treating neurodegenerative diseases, including Huntington’s Disease, Parkinson’s Disease and Frontotemporal Dementia. The lead ...

Theolytics

Theolytics is a clinical stage company, developing a new generation of oncolytic viruses for intravenous administration. The ability to specifically target tumour cells and the tumour micro-environme ...

VarmX

VarmX is a clinical stage company developing drugs that reverse the action of direct acting oral anticoagulants (DOACs).The lead program is a recombinant protein, VMX-C001, that addresses the need of ...
  1. Start
  2. Portfolio

Sound Bioventures is a venture capital fund investing in about-to-be clinical and clinical stage private companies in Europe and the USA developing novel medicines that addresses unmet medical needs.

Company

  • About
  • Team
  • Portfolio
  • Team Openings
  • News
  • Contact
  • Proposals

Contact & Press

  • Sustainability & SFDR
  • Privacy Policy
  • Subscribe to our newsletter
  • Press

Sound Bioventures Management AB
Org.no: 559310-0026
Nordenskiöldsgatan 11a
211 19 Malmö

Visiting address:
Sound Bioventures Management ApS
c/o Ordnung
Strandvejen 125
DK-2900 Hellerup, Denmark
Directions

Phone
+45 (0)60 - 63 31 20

General inquiries
info@soundbioventures.com

LinkedIn

© Copyright 2024 Sound Bioventures Management AB. All rights reserved. | We use cookies to improve our services

Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
  • Necessary
    These cookies are not optional. They are needed for the website to function.
  • Statistics
    In order for us to improve the website's functionality and structure, based on how the website is used.
  • Experience
    In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
  • Marketing
    By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.
Save Accept all